adrenal incidentalomas

  • 4% of Pts undergoing abdominal CT scan have incidentally discovered adrenal mass;
  • prevalence ↑ with age

Differential diagnosis

  • Nonfunctioning mass:
    • adenoma,
    • cysts,
    • abscesses,
    • granuloma,
    • hemorrhage,
    • lipoma,
    • myelolipoma,
    • primary or metastatic malignancy
  • Functioning mass:
    • pheochromocytoma,
    • adenoma (cortisol, aldosterone, sex hormones),
    • other endocrine tumor,
    • carcinoma

Hormonal workup (EJE 2016;175:G1; NEJM 2021;384:1542)

一般不做 bx

  • Rule out subclinical Cushing’s Syndrome
    • in all Pts using 1 mg overnight DST (Sp 91%).
    • Abnormal results require confirmatory testing.
  • Rule out hyperaldosteronism
    • if hypertensive w/ plasma aldo & renin (see above)
  • Rule out pheochromocytoma
    • in ALL Pts (b/c of morbidity unRx’d pheo)
    • using 24-h urine fractionated metanephrines or plasma fractionated metanephrines
  • Malignancy workup-adrenal incidentalomas

Follow-up

  • If hormonal workup ⊖ and appearance benign,
  • no further follow-up imaging needed,
  • but controversial (Annals 2019;171:107)

  • biochemical testing to detect pheochromocytoma and excess cortisol secretion, and those who also have high blood pressure should undergo biochemical testing to detect primary hyperaldosteronism
  • Patients with pheochromocytoma should undergo adrenalectomy after adequate presurgical alpha-blockade and beta-blockade, if necessary.
  • Patients with mild autonomous cortisol excess and primary hyperaldosteronism may benefit from adrenalectomy, but treatment should be individualized.
  • Nonfunctioning adrenal tumors that have an attenuation of 10 Hounsfield units or less on computed tomographic (CT) evaluation and that are smaller than 4 cm in greatest diameter generally do not warrant intervention or long-term follow-up.
  • All other adrenal incidentalomas with indeterminate features on imaging may warrant additional imaging with contrast-enhanced CT,
    • magnetic resonance imaging with chemical-shift analysis,
    • positron-emission tomography–CT with 18F-fluorodeoxyglucose, or all of these tests.